Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2021

The dividend is payable on April 16, 2021, to shareholders of record at the close of business on March 26, 2021.

The board of directors of Medtronic plc (NYSE: MDT) on Friday, March 5, 2021, approved the fiscal year 2021 fourth quarter cash dividend of $0.58 per ordinary share, representing a 7.4 percent increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in May 2020.  Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 43 consecutive years. 

About Medtronic

 

Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. 

Medtronic has been leveraging the unique strength of India beyond providing therapies to the patients in India. To take advantage of India’s strength with a large pool of qualified engineers, doctors with wide ranging patient pool experience & hospitals providing quality care, Medtronic established-

  • Medtronic Engineering and Innovation Centre, Hyderabad (MEIC) – a state of the art, IT-enabled, captive engineering R&D center in India. It provides high-quality, high-performance, cost-effective engineering services to Medtronic’s products and its global and regional business units, supporting their product development and other engineering functions.
  • Medtronic India Development Centre, Bangalore (MIDC) – The center focuses on key product, design and development aspects of the Renal Care Solutions business, which is currently developing a new hemodialysis system. MIDC aims to address the barriers that prevent wider availability of therapy for patients with end stage renal disease in emerging countries such as India. 
 

Contacts:

   

Erika Winkels

Ryan Weispfenning

Public Relations

Investor Relations

+1-763-526-8478

+1-763-505-4626

This article was shared to Prittle Prattle News as a Press Release.

By PR Newswire

What's your reaction?

Related Posts

1 of 82